Annual Review Meeting of the Three Diseases Fund
1-2 April 2008, Yangon
Objective
The first annual review of the Three Diseases Fund (3DF) has taken place on 1-2 April 2008 in Yangon. This annual review was the opportunity to review the fund’s performance, achievements to date and lessons learned.
Presentations
The red/brown links below show the presentations given at the review meeting (in Acrobat Reader).
Themes
Contribution to the overall national response and disease-specific key results.
Cross-cutting issues (coverage and access, engaging with local non-governmental and community-based organizations, communication, monitoring, procurement and resource management).
Agenda
DAY ONE
Tuesday 1 April—Morning
09:00–09:10 Opening remarks, Mark Canning, Fund Board Chair, Meeting Chairperson
09:10–09:20 Welcome address, Dr Kyaw Nyunt Sein, Deputy Director General Ministry of Health, Union of Myanmar
09:20–09:35 Review of the programme and introduction, Pr Dr Aung Tun Thet, Meeting Facilitator
09:35–10:15 Market place (tour of 3DF partners’ exhibition)
DISEASE-SPECIFIC PROGRESS AND PRIORITIES
10:15–12:35 HIV and AIDS (presentations and discussion = 2 h. 20)
• TSG policy and priorities (20 min.), Dr Saw Lwin, Director Disease Control, Chairperson
• The national response on HIV and AIDS (20 min.), Dr Min Thwe, Programme Manager
• Contribution and achievements by 3DF partners (40 min.), Habibur Rahmen (PSI), Willy Daemaree (AHRN) and Dr Frank Smithuis (MSF-H)
• Plenary discussion (1 h.)
Tuesday 1 April—Afternoon
CROSSCUTTING ISSUES
13:30-15:30 Coverage and access: challenges, successes and priority next steps (15 min.), Dr Aye Aye Than, IOM
• Engaging with LNGOs/CBOs (15 min.), Mikko Lainejoki, CEO Fund Manager
• Gender in 3DF programme (15 min.), Anne Bunning, consultant Fund Manager
• Communication: achievements to date and priority next steps (15 min.), Denise Jeanmonod, Communication Officer, Fund Manager
• Plenary discussion (1 h.)
15:45–16:45 Monitoring in 3DF programme
• WHO monitoring on Fund Flow mechanism (15 min.), Dr Hans Kluge, TB Officer WHO
• Overview of 3DF monitoring activities (15 min.), Dr Hadi Abdullahel, Evaluation and Monitoring Officer, Fund Manager
• Plenary discussion (30 min.)
16:45–17:30 Procurement and distribution: challenges and successes (15 min.), Peter Bollen, Procurement Officer, Fund Manager
• Plenary discussion (30 min.)
17:30–17:35 Sum up of the first day, Meeting Chairperson
DAY TWO
Wednesday 2 April—Morning
09:00–09:05 Welcome by Meeting Chair
09:05–09:10 Review of the programme by Meeting Facilitator
DISEASE-SPECIFIC PROGRESS AND PRIORITIES
09:10–10:30 Tuberculosis (presentations and discussion = 2 h. 30)
• TSG policy and priorities (20 min), Dr Saw Lwin, Director Disease Control, Chairperson
• The national response on TB (20 min), Dr Win Maung, Programme Manager
• Contribution and achievements by 3DF partners (40 min.), Dr Tin Aye (MMA), Birke Herzbroch (Malteser)
• Plenary discussion (1 h.)
Wednesday 2 April—Afternoon
DISEASE-SPECIFIC PROGRESS AND PRIORITIES
13:00–15:30 Malaria (presentations and discussion = 2 h. 30)
• TSG policy and priorities (20 min), Dr Saw Lwin, Director Disease Control, Chairperson
• The national response on malaria (20 min), Dr Than Win, Programme Manager
• Contribution and achievements by 3DF partners (40 min)
• Plenary discussion (1 h.)
15:30–16:15 Resource management (15 min.), Regina Carbonell, Finance Officer, and Mikko Lainejoki, CEO Fund Manager
• Plenary discussion (30 min.)
CLOSING SESSION
16:30–16:45 Sum up of disease-specific issues (15 min.), Anne Harmer and Michael O’Dwyer, Fund Board Members
16:45–17:00 Closing remarks, Mark Canning, Fund Board Chair, Meeting Chairperson
READ THE DISCLAIMER
